OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2013-07-19
- Target Recruit Count
- 843
- Registration Number
- NCT00705783
- Locations
- 🇨🇳
Otsuka Investigational Site, Taipei, Taiwan
A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)
- Conditions
- Tuberculosis, PulmonaryTuberculosis, Multidrug ResistantExtensively Drug-Resistant Tuberculosis
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2021-12-01
- Target Recruit Count
- 481
- Registration Number
- NCT00685360
- Locations
- 🇵🇪
Hospital Nacional Sergio E. Bernales, Lima, Peru
🇵🇪Hospital Nacional Hipolito Unanue, Unanue, Peru
🇵🇪Hospital Nacional Daniel Alcides Carrión, Carrion, Peru
Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
- Conditions
- Bipolar Disorder Mania
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 493
- Registration Number
- NCT00665366
- Locations
- 🇹🇷
Local Institution, Denizli, Turkey
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
- First Posted Date
- 2007-10-29
- Last Posted Date
- 2011-04-28
- Target Recruit Count
- 57
- Registration Number
- NCT00550459
- Locations
- 🇺🇸
Lillestol Research, LLC, Fargo, North Dakota, United States
🇺🇸Otis Barnum, DO, Natchitoches, Louisiana, United States
🇺🇸Carolina Research Associates, Columbia, South Carolina, United States
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Conditions
- Polycystic Kidney Disease, Autosomal Dominant
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 1445
- Registration Number
- NCT00428948
- Locations
- 🇺🇸
Apex Research of Riverside, Riverside, California, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸University Hospitals of Cleveland/Case, Cleveland, Ohio, United States
Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- First Posted Date
- 2006-12-20
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 46
- Registration Number
- NCT00413777
- Locations
- 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
- First Posted Date
- 2006-08-18
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 330
- Registration Number
- NCT00365859
- Locations
- 🇺🇸
Institute For Behavioral Medicine, Smyrna, Georgia, United States
🇺🇸Regions Hospital, St. Paul, Minnesota, United States
🇺🇸Harmonex Neuroscience, Dothan, Alabama, United States
Aripiprazole and Lexapro Drug Interaction Study
- Conditions
- Healthy
- First Posted Date
- 2006-08-09
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 25
- Registration Number
- NCT00361790
- Locations
- 🇺🇸
Local Institution, Lenexa, Kansas, United States
Aripiprazole and Effexor XR Drug Interaction Study
- Conditions
- Healthy
- First Posted Date
- 2006-08-09
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 38
- Registration Number
- NCT00362271
- Locations
- 🇺🇸
Local Institution, Miami, Florida, United States
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
- Locations
- 🇮🇳
Local Institution, Vishakhapatnam, India